LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · IEX Real-Time Price · USD
85.83
-0.41 (-0.48%)
Jul 26, 2024, 4:00 PM EDT - Market closed

LeMaitre Vascular Revenue

LeMaitre Vascular had revenue of $53.48M in the quarter ending March 31, 2024, with 13.60% growth. This brings the company's revenue in the last twelve months to $199.89M, up 18.16% year-over-year. In the year 2023, LeMaitre Vascular had annual revenue of $193.48M with 19.69% growth.

Revenue (ttm)
$199.89M
Revenue Growth
+18.16%
P/S Ratio
9.64
Revenue / Employee
$317,281
Employees
630
Market Cap
1.93B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023193.48M31.83M19.69%
Dec 31, 2022161.65M7.23M4.68%
Dec 31, 2021154.42M25.06M19.37%
Dec 31, 2020129.37M12.13M10.35%
Dec 31, 2019117.23M11.66M11.05%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Warby Parker 697.80M
Harmony Biosciences Holdings 617.51M
NeoGenomics 610.66M
NovoCure 549.96M
STAAR Surgical Company 326.24M
Zai Lab 291.07M
Mirum Pharmaceuticals 224.00M
Ligand Pharmaceuticals 118.31M
Revenue Rankings